210 related articles for article (PubMed ID: 24957555)
1. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.
Berner K; Johannesen TB; Berner A; Haugland HK; Bjerkehagen B; Bøhler PJ; Bruland ØS
Acta Oncol; 2015 Jan; 54(1):25-33. PubMed ID: 24957555
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis.
Papakonstantinou E; Athanasiadou KI; Markozannes G; Tzotzola V; Bouka E; Baka M; Moschovi M; Polychronopoulou S; Hatzipantelis E; Galani V; Stefanaki K; Strantzia K; Vousvouki M; Kourou P; Magkou E; Nikita M; Zambakides C; Michelarakis J; Alexopoulou A; Gavra M; Malama A; Ntzani EE; Petridou ET
Cancer Epidemiol; 2024 Jun; 90():102551. PubMed ID: 38447251
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
6. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
7. The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma.
Cao Z; Zhang Y; Xu Q; Yu X; Liu X; Dai M
Technol Cancer Res Treat; 2021; 20():15330338211066195. PubMed ID: 34918558
[No Abstract] [Full Text] [Related]
8. Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jan; 22(1):133-143. PubMed ID: 27847134
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
11. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of osteosarcoma.
Ottaviani G; Jaffe N
Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
[TBL] [Abstract][Full Text] [Related]
13. Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010.
Wiromrat P; Jetsrisuparb A; Komvilaisak P; Sirichativapee W; Kamsa-Ard S; Wiangnon S
Asian Pac J Cancer Prev; 2012; 13(9):4281-4. PubMed ID: 23167328
[TBL] [Abstract][Full Text] [Related]
14. Incidence, epidemiology and treatment results of osteosarcoma in Finland - a nationwide population-based study.
Sampo M; Koivikko M; Taskinen M; Kallio P; Kivioja A; Tarkkanen M; Böhling T
Acta Oncol; 2011 Nov; 50(8):1206-14. PubMed ID: 22023116
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002.
Eyre R; Feltbower RG; James PW; Blakey K; Mubwandarikwa E; Forman D; McKinney PA; Pearce MS; McNally RJ
BMC Cancer; 2010 Jul; 10():357. PubMed ID: 20604931
[TBL] [Abstract][Full Text] [Related]
16. The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database.
Aggerholm-Pedersen N; Maretty-Nielsen K; Keller J; Baerentzen S; Schrøder H; Jørgensen PH; Hansen BH; Nielsen OS; Safwat A
Acta Oncol; 2015 Jan; 54(1):17-24. PubMed ID: 24960582
[TBL] [Abstract][Full Text] [Related]
17. Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway.
Berner K; Zaikova O; Johannesen TB; Hall KS; Bruland ØS
J Surg Oncol; 2018 Jul; 118(1):246-247. PubMed ID: 30208205
[No Abstract] [Full Text] [Related]
18. Prognostic Impact of Proximal
Berner K; Bruland ØS
Anticancer Res; 2019 May; 39(5):2459-2466. PubMed ID: 31092440
[TBL] [Abstract][Full Text] [Related]
19. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.
Berner K; Bjerkehagen B; Bruland ØS; Berner A
Anticancer Res; 2015 Apr; 35(4):2129-40. PubMed ID: 25862869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
